0
Skip to Content
Pipeline
Pipeline Overview
Blood Cancers
Immunology & Inflammation
Solid Tumors
Publications & Abstracts
For Patients
Team
News
Open Menu
Close Menu
Pipeline
Pipeline Overview
Blood Cancers
Immunology & Inflammation
Solid Tumors
Publications & Abstracts
For Patients
Team
News
Open Menu
Close Menu
Folder:
Pipeline
Back
Pipeline Overview
Blood Cancers
Immunology & Inflammation
Solid Tumors
Publications & Abstracts
For Patients
Team
News
IO-202 Receives FDA Orphan Drug Designation for CMML
news
Feb 22
Written By
Lara Wilson
Lara Wilson
Previous
Previous
Here are some recent breakthroughs by women-led life sciences companies in the Bay Area
Next
Next
LLS TAP: Pushing Boundaries and Transforming Lives for Patients with Rare Blood Cancers